Futura Medical plc
FUM.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -1.14 | -0.23 | -0.02 |
| FCF Yield | -12.10% | 2.75% | -3.38% | -0.36% |
| EV / EBITDA | -3.11 | 175.95 | 117.96 | -13.51 |
| Quality | ||||
| ROIC | -217.39% | 2.09% | 12.13% | 0.00% |
| Gross Margin | 24.28% | 69.40% | 68.01% | 61.91% |
| Cash Conversion Ratio | 0.45 | 11.81 | -3.00 | -0.26 |
| Growth | ||||
| Revenue 3-Year CAGR | 700.89% | 712.22% | 533.56% | 327.39% |
| Free Cash Flow Growth | -215.85% | 166.33% | -1,318.49% | 54.58% |
| Safety | ||||
| Net Debt / EBITDA | 0.56 | -13.56 | -4.23 | 1.56 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 22.49 | 4.65 | 15,995.96 | 1,570.37 |
| Cash Conversion Cycle | -13.51 | -12.24 | 10.61 | -96.11 |